{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:45:37Z","timestamp":1790358337694,"version":"4.1.0"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HHS | National Institutes of Health","award":["R24GM137782"],"award-info":[{"award-number":["R24GM137782"]}]},{"name":"HHS | National Institutes of Health","award":["S10OD018530"],"award-info":[{"award-number":["S10OD018530"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:p>The tumor-associated antigen mesothelin is expressed at high levels on the cell surface of many human cancers, while its expression in normal tissues is limited. The binding of mesothelin to the tumor-associated cancer antigen 125 (CA-125) can lead to heterotypic cell adhesion and tumor metastasis within the pleural and peritoneal cavities. Immunotherapeutic strategies targeting mesothelin are being intensively investigated. Here, we report the crystal structures of mesothelin that reveal a compact, right-handed solenoid consisting of 24 short helices and connecting loops. These helices form a nine-layered spiral coil that resembles ARM\/HEAT family proteins. Glycan attachments have been identified in the structure for all three predicted N-glycosylation sites and confirmed with samples from cell culture and patient ascites. The structures of full-length mesothelin and its complex with the Fab of MORAb-009 reveal the interaction of the antibody with the complete epitope, which has not been reported previously. The N-terminal half of mesothelin is conformationally rigid, suitable for eliciting specific antibodies, whereas its C-terminal portion is more flexible. The structure of the C-terminal shedding-resistant fragment of mesothelin complexed with a mAb 15B6 displays an extended linear epitope and helps explain the protection afforded by the antibody for the shedding sites.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>The structures of full-length mesothelin and its complexes with antibodies reported here are the first to be determined experimentally, providing atomic models for structural organization of this protein and its interactions with antibodies. It offers insights into the function of mesothelin and guidance for further development of therapeutic antibodies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0306","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T10:49:28Z","timestamp":1674125368000},"page":"175-191","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-3663","authenticated-orcid":true,"given":"Jingyu","family":"Zhan","sequence":"first","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4433-6342","authenticated-orcid":true,"given":"Dong","family":"Lin","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-8058","authenticated-orcid":true,"given":"Nathan","family":"Watson","sequence":"additional","affiliation":[{"name":"2Laboratory of Molecular Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-6851","authenticated-orcid":true,"given":"Lothar","family":"Esser","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-1675","authenticated-orcid":true,"given":"Wai Kwan","family":"Tang","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-1993","authenticated-orcid":true,"given":"Alex","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7820-2783","authenticated-orcid":true,"given":"Xiufen","family":"Liu","sequence":"additional","affiliation":[{"name":"2Laboratory of Molecular Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-3633","authenticated-orcid":true,"given":"Raffit","family":"Hassan","sequence":"additional","affiliation":[{"name":"3Thoracic and GI Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-4339","authenticated-orcid":true,"given":"Anne","family":"Gleinich","sequence":"additional","affiliation":[{"name":"4Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4804-1130","authenticated-orcid":true,"given":"Asif","family":"Shajahan","sequence":"additional","affiliation":[{"name":"4Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-9432","authenticated-orcid":true,"given":"Parastoo","family":"Azadi","sequence":"additional","affiliation":[{"name":"4Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-0270","authenticated-orcid":true,"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[{"name":"2Laboratory of Molecular Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-0679","authenticated-orcid":true,"given":"Di","family":"Xia","sequence":"additional","affiliation":[{"name":"1Laboratory of Cell Biology, Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032314395449300_","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.MP.0000056981.16578.C3","article-title":"Value of mesothelin immunostaining in the diagnosis of mesothelioma","volume":"16","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Mod Pathol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1078-0432.CCR-06-2161","article-title":"Mesothelin expression in human lung cancer","volume":"13","author":"Ho","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.pai.00000141545.36485.d6","article-title":"Localization of mesothelin in epithelial ovarian cancer","volume":"13","author":"Hassan","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1200\/JCO.2016.68.3672","article-title":"Mesothelin immunotherapy for cancer: ready for prime time?","volume":"34","author":"Hassan","year":"2016","journal-title":"J Clin Oncol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"208ra147","DOI":"10.1126\/scitranslmed.3006941","article-title":"Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression","volume":"5","author":"Hassan","year":"2013","journal-title":"Sci Transl Med"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/cancers13163932","article-title":"Hitting the bull's-eye: mesothelin's role as a biomarker and therapeutic target for malignant pleural mesothelioma","volume":"13","author":"Yeo","year":"2021","journal-title":"Cancers"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"Ho","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1078-0432.CCR-05-1397","article-title":"Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma","volume":"12","author":"Yen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/9872","article-title":"Improving antibody affinity by mimicking somatic hypermutation in vitro","volume":"17","author":"Chowdhury","year":"1999","journal-title":"Nat Biotechnol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","article-title":"Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma","volume":"96","author":"Scholler","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1074\/jbc.M806776200","article-title":"A binding domain on mesothelin for CA125\/MUC16","volume":"284","author":"Kaneko","year":"2009","journal-title":"J Biol Chem"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1541-7786.MCR-19-0688","article-title":"Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases","volume":"18","author":"Avula","year":"2020","journal-title":"Mol Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1172\/JCI88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1074\/jbc.270.37.21984","article-title":"Molecular cloning and expression of megakaryocyte potentiating factor cDNA","volume":"270","author":"Kojima","year":"1995","journal-title":"J Biol Chem"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41419-019-1711-1","article-title":"Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6807-9-1","article-title":"Mesothelin, stereocilin, and otoancorin are predicted to have superhelical structures with ARM-type repeats","volume":"9","author":"Sathyanarayana","year":"2009","journal-title":"BMC Struct Biol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"33123","DOI":"10.1074\/jbc.M112.381756","article-title":"Recognition of mesothelin by the therapeutic antibody MORAb-009: structural and mechanistic insights","volume":"287","author":"Ma","year":"2012","journal-title":"J Biol Chem"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/1078-0432.CCR-05-0578","article-title":"New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA","volume":"11","author":"Onda","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","first-page":"20","article-title":"Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin","volume":"7","author":"Hassan","year":"2007","journal-title":"Cancer Immun"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1158\/1078-0432.CCR-06-0346","article-title":"Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice","volume":"12","author":"Zhang","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","article-title":"Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy","volume":"68","author":"Hassan","year":"2010","journal-title":"Lung Cancer"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ymthe.2019.07.015","article-title":"Phase I study of lentiviral-transduced chimeric antigen receptor-modified T cells recognizing mesothelin in advanced solid cancers","volume":"27","author":"Haas","year":"2019","journal-title":"Mol Ther"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1891","article-title":"Immunotoxin therapy of cancer","volume":"6","author":"Pastan","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1158\/0008-5472.CAN-11-0466","article-title":"Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s42003-020-01464-5","article-title":"Multiple proteases are involved in mesothelin shedding by cancer cells","volume":"3","author":"Liu","year":"2020","journal-title":"Commun Biol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"e2202439119","DOI":"10.1073\/pnas.2202439119","article-title":"Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin","volume":"119","author":"Liu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1107\/S0021889808033797","article-title":"The use of blue native PAGE in the evaluation of membrane protein aggregation states for crystallization","volume":"41","author":"Ma","year":"2008","journal-title":"J Appl Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444907050172","article-title":"BALBES: a molecular-replacement pipeline","volume":"64","author":"Long","year":"2008","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suit: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1107\/S0021889897006766","article-title":"MOLREP: an automated program for molecular replacement","volume":"30","author":"Vagin","year":"1997","journal-title":"J Appl Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1107\/S0108767389009815","article-title":"The molecular replacement method","volume":"46","author":"Rossmann","year":"1990","journal-title":"Acta Crystallogr A"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1016\/S0969-2126(99)80060-4","article-title":"Turn up the HEAT","volume":"7","author":"Kobe","year":"1999","journal-title":"Structure"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"e2202439119","DOI":"10.1073\/pnas.2202439119","article-title":"Highly active CAR T cells that bind to a juxta-membrane region of mesothelin and are not blocked by shed mesothelin","volume":"119","author":"Liu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2174\/138945007782151360","article-title":"Protein N-glycosylation in the baculovirus-insect cell system","volume":"8","author":"Shi","year":"2007","journal-title":"Curr Drug Targets"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/7625","article-title":"Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha","volume":"6","author":"Kobe","year":"1999","journal-title":"Nat Struct Biol"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0092-8674(00)80352-9","article-title":"Three-dimensional structure of the armadillo repeat region of beta-catenin","volume":"90","author":"Huber","year":"1997","journal-title":"Cell"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nmeth.2727","article-title":"Quantifying the local resolution of cryo-EM density maps","volume":"11","author":"Kucukelbir","year":"2014","journal-title":"Nat Methods"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1038\/srep09928","article-title":"New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"2023032314395449300_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lungcan.2008.02.012","article-title":"Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin","volume":"62","author":"Iwahori","year":"2008","journal-title":"Lung Cancer"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0306\/3262462\/crc-22-0306.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/2\/175\/3285665\/crc-22-0306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/2\/175\/3285665\/crc-22-0306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T20:47:27Z","timestamp":1701722847000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/2\/175\/716321\/Structures-of-Cancer-Antigen-Mesothelin-and-Its"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0306","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22546340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546331","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546340.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546337","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551150","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551150.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546337.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546334.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546334","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546331.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}